| Firm |
Analyst |
| Barclays Capital |
Gena Wang, Ph.D., CFA |
| BMO Capital |
Do Kim, CFA |
| Canaccord Genuity |
Arlinda Lee, Ph.D. |
| Cantor Fitzgerald |
Charles Duncan, Ph.D. |
| Citi |
Joel Beatty, M.D., CFA |
| Goldman Sachs |
Dana Flanders |
| Jefferies & Company |
Eun K. Yang, Ph.D. |
| JMP Securities |
Jason N. Butler, Ph.D. |
| JP Morgan |
Jessica Fye |
| Wells Fargo |
Jim Birchenough, M.D. |
Halozyme Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Halozyme Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Halozyme Therapeutics, Inc. or its management. Halozyme Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.